Literature DB >> 32675866

ENERGY SENSING PATHWAYS IN AGING AND CHRONIC LUNG DISEASE.

Victor J Thannickal1.   

Abstract

Aging is associated with an increased risk of a number of clinical syndromes, including chronic lung disease. There have been significant advances in our understanding of the biology of aging leading to the elucidation of the so-called "hallmarks of aging." The cause-effect relationships between various hallmarks such as dysregulated nutrient sensing, mitochondrial dysfunction, and cellular senescence are not well understood. Here, I discuss the evidence for alterations in energy/metabolic sensing pathways in the degenerative chronic lung disease called idiopathic pulmonary fibrosis (IPF). The pathobiological mechanisms by which this defect may contribute to age-related susceptibility to IPF and potentially other diseases of the elderly are also discussed.
© 2020 The American Clinical and Climatological Association.

Entities:  

Year:  2020        PMID: 32675866      PMCID: PMC7358504     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  37 in total

Review 1.  Evolving concepts of apoptosis in idiopathic pulmonary fibrosis.

Authors:  Victor J Thannickal; Jeffrey C Horowitz
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 2.  Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Authors:  Mary Armanios
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

Review 3.  Developmental pathways in the pathogenesis of lung fibrosis.

Authors:  Diptiman Chanda; Eva Otoupalova; Samuel R Smith; Thomas Volckaert; Stijn P De Langhe; Victor J Thannickal
Journal:  Mol Aspects Med       Date:  2018-08-23

4.  Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.

Authors:  Louise Hecker; Naomi J Logsdon; Deepali Kurundkar; Ashish Kurundkar; Karen Bernard; Thomas Hock; Eric Meldrum; Yan Y Sanders; Victor J Thannickal
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

5.  Geroscience: linking aging to chronic disease.

Authors:  Brian K Kennedy; Shelley L Berger; Anne Brunet; Judith Campisi; Ana Maria Cuervo; Elissa S Epel; Claudio Franceschi; Gordon J Lithgow; Richard I Morimoto; Jeffrey E Pessin; Thomas A Rando; Arlan Richardson; Eric E Schadt; Tony Wyss-Coray; Felipe Sierra
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

6.  Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis.

Authors:  Charlene D Fell; Fernando J Martinez; Lyrica X Liu; Susan Murray; Meilan K Han; Ella A Kazerooni; Barry H Gross; Jeffrey Myers; William D Travis; Thomas V Colby; Galen B Toews; Kevin R Flaherty
Journal:  Am J Respir Crit Care Med       Date:  2010-01-07       Impact factor: 21.405

7.  Pharmacological characterization of the seven human NOX isoforms and their inhibitors.

Authors:  Fiona Augsburger; Aleksandra Filippova; Delphine Rasti; Tamara Seredenina; Magdalena Lam; Ghassan Maghzal; Zahia Mahiout; Pidder Jansen-Dürr; Ulla G Knaus; James Doroshow; Roland Stocker; Karl-Heinz Krause; Vincent Jaquet
Journal:  Redox Biol       Date:  2019-07-11       Impact factor: 11.799

Review 8.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases.

Authors:  Boris Hinz; David Lagares
Journal:  Nat Rev Rheumatol       Date:  2019-12-02       Impact factor: 20.543

9.  Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Jeffrey L Myers; Luca Richeldi; Christopher J Ryerson; David J Lederer; Juergen Behr; Vincent Cottin; Sonye K Danoff; Ferran Morell; Kevin R Flaherty; Athol Wells; Fernando J Martinez; Arata Azuma; Thomas J Bice; Demosthenes Bouros; Kevin K Brown; Harold R Collard; Abhijit Duggal; Liam Galvin; Yoshikazu Inoue; R Gisli Jenkins; Takeshi Johkoh; Ella A Kazerooni; Masanori Kitaichi; Shandra L Knight; George Mansour; Andrew G Nicholson; Sudhakar N J Pipavath; Ivette Buendía-Roldán; Moisés Selman; William D Travis; Simon Walsh; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2018-09-01       Impact factor: 21.405

10.  Metformin reverses established lung fibrosis in a bleomycin model.

Authors:  Sunad Rangarajan; Nathaniel B Bone; Anna A Zmijewska; Shaoning Jiang; Dae Won Park; Karen Bernard; Morgan L Locy; Saranya Ravi; Jessy Deshane; Roslyn B Mannon; Edward Abraham; Victor Darley-Usmar; Victor J Thannickal; Jaroslaw W Zmijewski
Journal:  Nat Med       Date:  2018-07-02       Impact factor: 53.440

View more
  1 in total

1.  Systems biology analysis of lung fibrosis-related genes in the bleomycin mouse model.

Authors:  Dmitri Toren; Hagai Yanai; Reem Abu Taha; Gabriela Bunu; Eugen Ursu; Rolf Ziesche; Robi Tacutu; Vadim E Fraifeld
Journal:  Sci Rep       Date:  2021-09-29       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.